Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome

Archives of Disease in Childhood

Volumn 75, Issue 5, 1996, Pages 436-439

  Litzman, J ^a,d   Jones, A ^b   Hann, I ^b   Chapel, H ^c   Strobel, S ^b   Morgan, G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Intravenous immunoglobulin; Splenectomy; Thrombocytopenia; Wiskott Aldrich syndrome

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; COTRIMOXAZOLE; FLUCONAZOLE; IMMUNOGLOBULIN G;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CLINICAL ARTICLE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

EID: 0029903853     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.5.436     Document Type: Article

References (25)

1. Standen GR. Wiskott-Aldrich syndrome: new perspectives in pathogenesis and management. J R Coll Physicians Lond 1988;22:80-3.
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-44.
3. Rimm IJ, Rappeport JM. Bone marrow transplantation for the Wiskott-Aldrich syndrome. Long-term follow-up. Transplantation 1990;50:617-20.
4. Brochstein JA, Gillio AP, Ruggiero M, et al. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. J Pediatr 1991;119:907-12.
5. Lenarsky C, Weinberg K, Kohn DB, Parkman R. Unrelated donor BMT for Wiskott-Aldrich syndrome. Bone Marrow Transplant 1993;12:145-7.
6. Mullen CA, Anderson KD, Blaese RM. Splenectomy and /or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood 1993;82:2961-6.
7. Fischer A, Landais P, Friedrich W, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European group for immunodeficiency. Blood 1994;83: 1149-54.
8. Perry GS III, Spector BD, Schuman LM, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr 1980;97:72-8.
9. Lum LG, Tubergen DG, Corash L, Blaese RM. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N Engl J Med 1980;302:892-6.
10. Hong R, Clement LT, Gatti RA, Kirkpatrick CH. Disorders of the T-cell system. In: Stiehm ER, ed. Immunologic disorders in infants and children. 4th Ed. Philadelphia: W B Saunders, 1996: 339-404.
11. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multi-institutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994;125:876-85.
12. Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood 1985;65: 1439-43.
13. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 1980;55: 243-52.
14. de Martino M, Galli L, Azzari C, Zammarchi E, Vierucci A. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome. Vox Sang 1994;67:317-9.
15. Scott M, Oski FA, Naiman JL, Lusch CJ, Goldberg S, Gardner FH. Platelet size and kinetics in hereditary and acquired thrombocytopenia. N Engl J Med 1972;286:499-504.
16. Marone G, Albini F, Di Martino L, Quattrin S, Poto S, Condorelli M. The Wiskott-Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes. Br J Haematol 1986;62:737-45.
17. Gröttum KA, Hovig T, Holmsen H, Foss Abrahamsen A, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol 1969;17:373-88.
18. Kuramoto A, Steiner M, Baldini MG. Lack of platelet response to stimulation in the Wiskott-Aldrich syndrome. N Engl J Med 1970;282:475-9.
19. Kenney DM, Reid R, Parent DW, Rosen FS, Remold-O'Donnell E. Evidence implicating calpain (Ca2+-dependent neutral protease) in the destructive thrombocy-topenia of the Wiskott-Aldrich syndrome. Br J Haematol 1994;87:773-81.
20. Wodzinski MA, Lilleyman JS. High-dose immunoglobulin therapy of Wiskott-Aldrich syndrome. Pediatr Hematol Oncol 1987;4:345-8.
21. Mathew P, Conley ME. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome. Pediatr Allergy Immunol 1995;6: 91-4.
22. Weiden PL, Blaese RM. Hereditary thrombocytopenia: relation to Wiskott-Aldrich syndrome with special reference to splenectomy. J Pediatr 1972;80:226-34.
23. Ammann AJ, Hong R. Disorders of the T-cell system. In: Stiehm ER, ed. Immunologic disorders in infants and children. 3rd Ed. Philadelphia: W B Saunders, 1989: 257-315.
24. Blaese RM, Strober W, Brown RS, Waldmann TA. The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet 1968;i: 1056-61.
25. Cooper MD, Chase HP, Lowman JT, Krivit W, Good RA. Wiskott-Aldrich syndrome: an immunologic deficiency disease involving the afferent limb of immunity. Am J Med 1968;44:499-513.